Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hayato Tada

Showing results (261-270 of 306) with videos related to

Pageof 31
Sort By:
Journal of Atherosclerosis and Thrombosis|April 28, 2021
Diagnosis and Management of Sitosterolemia 2021Hayato Tada, Akihiro Nomura, Masatsune Ogura, et al.
Journal of Diabetes Investigation|January 29, 2022
Fragmented QRS on electrocardiography as a predictor for diastolic cardiac dysfunction in type 2 diabetesKunimasa Yagi, Teruhiko Imamura, Hayato Tada, et al.
Journal of Atherosclerosis and Thrombosis|July 1, 2026
Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 TrialMasahiro Koseki, Hisashi Makino, Yoshihiko Otsubo, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results From a Study of Patients Carrying Gene MutationsKenshi Hayashi, Tetsuo Konno, Noboru Fujino, et al.
Rheumatology Advances in Practice|December 13, 2023
A case of sitosterolaemia-caused systemic large-vessel stenosis mimicking Takayasu arteritis in which FDG-PET provided a clue for the differential diagnosisTakato Nakadoi, Eri Katsuyama, Kazuya Matsumoto, et al.
Atherosclerosis|July 12, 2014
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutationHiroshi Mabuchi, Atsushi Nohara, Tohru Noguchi, et al.
Circulation. Cardiovascular Genetics|December 14, 2011
Altered metabolism of low-density lipoprotein and very-low-density lipoprotein remnant in autosomal recessive hypercholesterolemia: results from stable isotope kinetic study in vivoHayato Tada, Masa-aki Kawashiri, Katsunori Ikewaki, et al.
Journal of Diabetes Research|April 15, 2021
Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection FractionKunimasa Yagi, Teruhiko Imamura, Hayato Tada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2026
Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry StudyHayato Tada, Yasuaki Takeji, Chiaki Goten, et al.
Journal of Atherosclerosis and Thrombosis|June 28, 2021
Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, JapanKeiji Matsunaga, Asako Mizobuchi, Hai Ying Fu, et al.
Pageof 31

Showing results (261-270 of 306) with videos related to

Sort By:
Pageof 31
Journal of Atherosclerosis and Thrombosis|April 28, 2021
Diagnosis and Management of Sitosterolemia 2021Hayato Tada, Akihiro Nomura, Masatsune Ogura, et al.
Journal of Diabetes Investigation|January 29, 2022
Fragmented QRS on electrocardiography as a predictor for diastolic cardiac dysfunction in type 2 diabetesKunimasa Yagi, Teruhiko Imamura, Hayato Tada, et al.
Journal of Atherosclerosis and Thrombosis|July 1, 2026
Efficacy and Safety of Evinacumab in Japanese Patients with Homozygous Familial Hypercholesterolemia: Long-term Results from an Open-label, Single-arm, Phase 3 TrialMasahiro Koseki, Hisashi Makino, Yoshihiko Otsubo, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results From a Study of Patients Carrying Gene MutationsKenshi Hayashi, Tetsuo Konno, Noboru Fujino, et al.
Rheumatology Advances in Practice|December 13, 2023
A case of sitosterolaemia-caused systemic large-vessel stenosis mimicking Takayasu arteritis in which FDG-PET provided a clue for the differential diagnosisTakato Nakadoi, Eri Katsuyama, Kazuya Matsumoto, et al.
Atherosclerosis|July 12, 2014
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutationHiroshi Mabuchi, Atsushi Nohara, Tohru Noguchi, et al.
Circulation. Cardiovascular Genetics|December 14, 2011
Altered metabolism of low-density lipoprotein and very-low-density lipoprotein remnant in autosomal recessive hypercholesterolemia: results from stable isotope kinetic study in vivoHayato Tada, Masa-aki Kawashiri, Katsunori Ikewaki, et al.
Journal of Diabetes Research|April 15, 2021
Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection FractionKunimasa Yagi, Teruhiko Imamura, Hayato Tada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 22, 2026
Impact of Genetic Testing Among Patients With Familial Hypercholesterolemia on Adverse Cardiovascular Events　- The Hokuriku-Plus Familial Hypercholesterolemia Registry StudyHayato Tada, Yasuaki Takeji, Chiaki Goten, et al.
Journal of Atherosclerosis and Thrombosis|June 28, 2021
Universal Screening for Familial Hypercholesterolemia in Children in Kagawa, JapanKeiji Matsunaga, Asako Mizobuchi, Hai Ying Fu, et al.
Pageof 31